Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
[2012: Update on diagnosis and treatment of multiple sclerosis].
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.
Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine.
Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis.
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Connective Tissue and its Growth Factor, CTGF, Distinguish the Morphometric and Molecular Remodeling of the Bladder in a Model of Neurogenic Bladder.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.
Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project'
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
The prospects of minocycline in multiple sclerosis.
Risk of vascular disease in patients with multiple sclerosis: a review.
Update on biomarkers in neuromyelitis optica.
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis.
Targeting IRF4 in autoimmune diseases.
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels.
Neuromyelitis optica with very late onset.
Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag.
Epitope spreading in immune-mediated diseases: implications for immunotherapy.
Pages
« first
‹ previous
…
141
142
143
144
145
146
147
148
149
…
next ›
last »